HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David J Moliterno Selected Research

Chronic Renal Insufficiency

9/2022Ticagrelor monotherapy after PCI in patients with concomitant diabetes mellitus and chronic kidney disease: TWILIGHT DM-CKD.
12/2021Ticagrelor monotherapy in patients with chronic kidney disease undergoing percutaneous coronary intervention: TWILIGHT-CKD.
1/2018Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients).
1/2009In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David J Moliterno Research Topics

Disease

68Hemorrhage
01/2023 - 01/2002
65Myocardial Infarction
10/2023 - 01/2002
62Acute Coronary Syndrome
11/2022 - 01/2002
38Thrombosis (Thrombus)
01/2020 - 02/2002
24Stroke (Strokes)
10/2023 - 12/2002
14Cardiovascular Diseases (Cardiovascular Disease)
01/2020 - 07/2006
12ST Elevation Myocardial Infarction
01/2018 - 02/2002
10Ischemia
03/2017 - 12/2002
8Atrial Fibrillation
01/2021 - 07/2009
8Death (Near-Death Experience)
01/2020 - 11/2013
6Thrombocytopenia (Thrombopenia)
11/2009 - 05/2004
5Infarction (Infarctions)
06/2013 - 02/2002
4Chronic Renal Insufficiency
09/2022 - 01/2009
4Diabetes Mellitus
09/2022 - 12/2003
4Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 10/2011
4Anemia
01/2019 - 10/2004
4Heart Failure
10/2013 - 06/2012
3Peripheral Arterial Disease
10/2023 - 10/2006
3Peripheral Vascular Diseases (Peripheral Vascular Disease)
11/2018 - 09/2003
3Shock
10/2013 - 05/2008
3Myocardial Ischemia (Ischemic Heart Diseases)
09/2012 - 10/2004
3Inflammation (Inflammations)
07/2012 - 02/2002
3Unstable Angina
12/2008 - 07/2002
2Obesity
10/2023 - 04/2006
2Thromboembolism
01/2021 - 07/2009
2Intracranial Hemorrhages (Intracranial Hemorrhage)
12/2018 - 01/2012
2Non-ST Elevated Myocardial Infarction
01/2018 - 02/2012
2Coronary Thrombosis
05/2016 - 02/2008
2Necrosis
11/2013 - 07/2012
2Hypertension (High Blood Pressure)
12/2003 - 12/2003
1Dyspnea (Shortness of Breath)
10/2023
1Hypercholesterolemia
10/2023
1Overweight
10/2022
1Hemorrhagic Stroke
12/2018
1Embolic Stroke
11/2016
1Albuminuria
08/2016
1Acute Kidney Injury (Acute Renal Failure)
08/2016
1Heart Diseases (Heart Disease)
11/2013

Drug/Important Bio-Agent (IBA)

27Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2023 - 04/2002
22vorapaxarIBA
12/2018 - 03/2009
17Thrombin Receptors (Thrombin Receptor)IBA
12/2018 - 01/2012
152'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2023 - 11/2013
12Glycoproteins (Glycoprotein)IBA
01/2018 - 01/2002
12Clopidogrel (Plavix)FDA Link
05/2016 - 10/2003
12Abciximab (ReoPro)FDA Link
06/2011 - 01/2002
11Tirofiban (Aggrastat)FDA Link
06/2011 - 05/2002
11Heparin (Liquaemin)FDA LinkGeneric
11/2009 - 08/2002
10TicagrelorIBA
10/2023 - 01/2014
10Platelet Membrane Glycoprotein IIbIBA
05/2015 - 10/2002
9AnticoagulantsIBA
01/2021 - 07/2003
7ThrombinFDA Link
01/2015 - 02/2002
6omega-Chloroacetophenone (Mace)IBA
10/2019 - 11/2013
6thienopyridineIBA
03/2017 - 02/2007
6Platelet Membrane GlycoproteinsIBA
02/2008 - 01/2002
6paragonIBA
02/2008 - 07/2002
5CreatinineIBA
01/2018 - 12/2003
5Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
12/2015 - 04/2002
4Peptide Hydrolases (Proteases)FDA Link
12/2018 - 03/2014
4MetalsIBA
09/2014 - 09/2006
4Biomarkers (Surrogate Marker)IBA
05/2014 - 07/2012
3Vitamin KFDA Link
01/2021 - 08/2012
3PAR-1 ReceptorIBA
12/2015 - 07/2014
3Warfarin (Coumadin)FDA LinkGeneric
08/2012 - 10/2011
3AntithrombinsIBA
02/2012 - 02/2002
3Enoxaparin (Lovenox)FDA LinkGeneric
04/2005 - 01/2003
2TroponinIBA
01/2014 - 11/2013
2pro-brain natriuretic peptide (1-76)IBA
10/2013 - 07/2012
2Proteinase-Activated ReceptorsIBA
06/2013 - 09/2012
2Digoxin (Digitek)FDA LinkGeneric
05/2013 - 08/2011
2Fibrinogen (Factor I)FDA Link
09/2012 - 01/2005
2Interleukin-6 (Interleukin 6)IBA
07/2012 - 12/2003
2N(2)-(3-trifluoromethylphenyl)guanineIBA
11/2009 - 05/2008
2pexelizumabIBA
11/2009 - 05/2008
2Eptifibatide (Integrilin)FDA Link
02/2008 - 07/2002
2Fibrinolytic Agents (Antithrombotic Agents)IBA
08/2006 - 04/2002
2sibrafibanIBA
08/2003 - 06/2002
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
12/2002 - 10/2002
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
06/2002 - 02/2002
1Hemoglobins (Hemoglobin)IBA
01/2019
1protease-activated receptor 4IBA
01/2018
1SuspensionsIBA
10/2017
1apixabanIBA
01/2016
1trans-crotonin (CTN)IBA
11/2013
1ThromboxanesIBA
09/2012
1Adenosine Diphosphate (ADP)IBA
09/2012
1Dicumarol (Dicoumarol)FDA Link
08/2012
1CytokinesIBA
07/2012

Therapy/Procedure

56Therapeutics
01/2023 - 01/2002
43Percutaneous Coronary Intervention
10/2023 - 01/2002
41Stents
01/2021 - 01/2002
13Drug-Eluting Stents
03/2022 - 09/2006
9Patient Readmission
03/2017 - 11/2009
7Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2023 - 12/2002
4Thrombolytic Therapy
08/2006 - 02/2002
3Secondary Prevention
12/2018 - 06/2002
3Blood Transfusion (Blood Transfusions)
07/2013 - 05/2004
2Length of Stay
01/2018 - 01/2009
2Transcatheter Aortic Valve Replacement
09/2012 - 06/2012
2Combination Drug Therapy (Combination Chemotherapy)
04/2002 - 02/2002
1Polypharmacy
12/2012